Highlights Ildong Holdings Co., Ltd.

Equities

A000230

KR7000230003

End-of-day quote Korea S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
7,990 ^KRW	-1.60%		-5.44%	-24.05%

14/03	Ildong Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Ildong Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ildong Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03	CI
Ildong Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Ildong Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Ildong Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Ildong Holdings Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
Twist Bioscience, Ildong Pharmaceutical Partner to Discover Antibodies for Immuno-Oncology	30/22/30	MT
Ildong Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
Ildong Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	17/22/17	CI
Ildong Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/21/15	CI
Ildong Holdings Co., Ltd. acquired 5.18% stake in Ildong Pharmaceutical Co., Ltd. from Il-dong Foods Co. Ltd. and Lee, Keumki for KRW 22.4 billion.	27/19/27	CI
Ildong Holdings Co., Ltd. completed the acquisition of 19.25% stake in Ildong Pharmaceutical Co., Ltd. for KRW 65.4 billion.	28/17/28	CI
Ildong Holdings Co., Ltd. made a tender offer to acquire an additional 29.14% stake in Ildong Pharmaceutical Co., Ltd. for KRW 98.9 billion.	06/17/06	CI
Ildong Pharmaceutical Co., Ltd. completed the Spin-Off of its pharmaceutical business division for KRW 518.3 billion.	01/16/01	CI
Ildong Pharmaceutical Co., Ltd. agreed to spin-off its pharmaceutical business division.	09/16/09	CI
IlDong Pharmaceutical Announces Earnings Results for the Third Quarter of Fiscal 2015	27/15/27	CI
Invest Sun Co., Ltd. acquired 9.36% stake in Ildong Pharmaceutical Co., Ltd. from Green Cross Corp. and others for KRW 44.6 billion.	05/15/05	CI
Won-Young Yoon completed the acquisition of 29.36% stake in Ildong Pharmaceutical Co., Ltd. from Green Cross Corp., Green Cross Holdings Corporation and Green Cross Cell corporation.	29/15/29	CI
Won-Young Yoon signed an agreement to acquire 29.36% stake in Ildong Pharmaceutical Co., Ltd. from Green Cross Corp., Green Cross Holdings Corporation and Green Cross Cell corporation for approximately KRW 140 billion.	29/15/29	CI
Ildong Pharmaceutical Reports Earnings Results for the First Quarter of 2015	13/15/13	CI
Arena Pharmaceuticals GmbH Appoints Ildong Pharmaceutical Co., Ltd. as Distributer in South Korea	03/15/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Ildong Holdings Co., Ltd.

Equities

A000230

KR7000230003

Highlights

Filters